FENNEC PHARMACEUTICALS INC

Historical 13F Holders

Symbol
FENC
CUSIP
31447P100
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 31447P100 since 12/18/2024, largest first.

Filer % of Class Filed
Rosalind Advisors, Inc. 13G/A
9.6% 8/13/2026
Event 6/30/2026
Sonic Fund II, L.P. 13G/A
8.2% 2/17/2026
Event 12/31/2025
Orin Hirschman 13G
5.7% 4/28/2026
Event 3/31/2026
Solas Capital Management, LLC 13G/A
5.4% 8/14/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
DG Capital Management, LLC 13G/A
4.1% 2/14/2025
Event 12/31/2024
Southpoint Capital Advisors LP 13G/A
0% 8/14/2026
Event 6/30/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 3 618 $6.58 k
2026 Q2 108 16.3 M $175 M
2026 Q1 92 16.2 M $99.6 M
2025 Q4 97 15.5 M $120 M
2025 Q3 86 13.9 M $130 M
2025 Q2 80 13.6 M $113 M
2025 Q1 70 13.4 M $81.6 M
2024 Q4 65 16.0 M $101 M
2024 Q3 66 14.9 M $74.7 M
2024 Q2 67 14.5 M $88.4 M
2024 Q1 73 14.6 M $163 M
2023 Q4 63 15.1 M $170 M
2023 Q3 61 14.3 M $108 M
2023 Q2 62 14.1 M $125 M
2023 Q1 59 13.0 M $108 M
2022 Q4 48 12.5 M $120 M
2022 Q3 44 11.4 M $92.1 M
2022 Q2 32 11.3 M $63.2 M
2022 Q1 32 11.4 M $64.1 M
2021 Q4 36 11.5 M $50.5 M
2021 Q3 36 11.6 M $110 M
2021 Q2 42 12.1 M $88.0 M
2021 Q1 55 18.5 M $115 M
2020 Q4 56 14.5 M $108 M
2020 Q3 59 13.8 M $83.8 M
2020 Q2 59 13.9 M $116 M
2020 Q1 32 9.47 M $56.3 M
2019 Q4 32 10.1 M $65.7 M
2019 Q3 28 8.47 M $40.7 M
2019 Q2 33 8.99 M $36.0 M
2019 Q1 50 9.64 M $46.7 M
2018 Q4 49 9.78 M $62.4 M
2018 Q3 52 9.48 M $77.8 M
2018 Q2 47 9.68 M $101 M
2018 Q1 23 7.65 M $92.5 M
2017 Q4 18 7.16 M $72.3 M
2017 Q3 13 5.21 M $57.7 M